Generic Name and Formulations:
Temazepam 7.5mg, 15mg, 22.5mg, 30mg; caps.
Indications for RESTORIL:
Short-term (7–10 days) treatment of insomnia.
Use lowest effective dose. Usual dose: 7.5mg–30mg at bedtime. Elderly or debilitated: initially 7.5mg. Max 1 month/℞.
<18yrs: not established.
Risks from concomitant use with opioids (see Interactions). Suicidal tendencies. Depression. Pulmonary, renal, or hepatic impairment. Drug or alcohol abuse. Reevaluate if used ≥2 weeks. Sleep disturbances after stopping drug. Avoid abrupt cessation after prolonged use. Elderly. Nursing mothers.
Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Additive CNS depressant effects with alcohol or other CNS depressants.
Drowsiness, headache, fatigue, nervousness, lethargy, dizziness, hangover, confusion, weakness, paradoxical excitement, euphoria; sleep-driving and other complex behaviors (eg, preparing/eating food), anaphylaxis, angioedema.
Caps 7.5mg—30, 100; 22.5mg—30; 15mg, 30mg—100